Monday, January 17, 2022

Official: Iran’s PasteuCovac jab 96.5% effective against Covid

More Articles

Avatar of IFP Editorial Staff
IFP Editorial Staffhttps://ifpnews.com/ifp-editorial-staff
The IFP Editorial Staff is composed of dozens of skilled journalists, news-writers, and analysts whose works are edited and published by experienced editors specialized in Iran News. The editor of each IFP Service is responsible for the report published by the Iran Front Page (IFP) news website, and can be contacted through the ways mentioned in the "IFP Editorial Staff" section.
The director of Iran’s Pasteur Institute has said tests on 24,000 people show that the country’s PasteuCovac vaccine is 96.5 percent effective against Covid-19.

Ali Es-haghi added that this level of immunity protects people from powerful variants of Covid.

Es-haghi also said the first shipment of another jab named CovPars including 5 million doses is ready for delivery to the Ministry of Health.

He noted that CovPars is more effective against the Omicron strain of Covid than on Delta.

Meanwhile, a member of Iran’s National Headquarters Against COVID-19 has said research shows that Covid vaccine boosters doubles body’s immunity to the virus. He also hailed the downward trend in Covid deaths and infections but warned against complacency or relaxation of health protocols, adding that it’s likely Omicron will invade Iran in the coming weeks.

Latest article